Lindsey Rolfe, See Remarks at Clovis Oncology, Inc. (CLVS), sold 680 shares at $7.03 ($5K) on 2020-06-03, disclosed to the SEC on 2020-06-05.
Open-market sale of $5k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.03 | 324 | $2K | 47.6% |
| 2 | $7.03 | 356 | $3K | 52.4% |
| Total | $7.03 avg | 680 | $5K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $2K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $8K | — | Filing → |